Inventor · disambiguated record
Zhiqiang Yang
Also filed as: YANG ZHIQIANG
13 granted patents·6 pending applications·13 citations·filing 2006–2021
84Inventor score
Top patents by PatentIndex Score
19 records- 0183US9822130B2Triazolo-pyrazinyl derivatives useful as soluble guanylate cyclase activatorsMERCK SHARP & DOHME·Filed 2015·Granted Nov 21, 2017·6 cites·47 claims
- 0279US7745452B2Quinazolinone T-type calcium channel antagonistsMERCK SHARP & DOHME·Filed 2006·Granted Jun 29, 2010·4 cites·12 claims
- 0375US10213429B2Imidazo-pyrazinyl derivatives useful as soluble guanylate cyclase activatorsMERCK SHARP & DOHME·Filed 2016·Granted Feb 26, 2019·2 cites·18 claims
- 0469US8501773B24-fluoro-piperidine T-type calcium channel antagonistsBARROW JAMES C·Filed 2006·Granted Aug 6, 2013·1 cites·10 claims
- 0558US10322140B2Preparation and use of 7a-heterocycle substituted-6,6-difluoro bicyclic himbacine derivatives as PAR-1 receptor antagonistsMERCK SHARP & DOHME·Filed 2017·Granted Jun 18, 2019·0 cites·13 claims
- 0656US9701669B2Preparation and use of 7a-amide substituted- 6,6-difluoro bicyclic himbacine derivatives as PAR-1 receptor antagonistsMERCK SHARP & DOHME·Filed 2014·Granted Jul 11, 2017·0 cites·13 claims
- 0756US2023105982A1Insulin-incretin conjugatesMERCK SHARP & DOHME·Filed 2021·Application pending·0 cites
- 0855US2016200715A1Preparation and use of 7a-heterocycle substituted- 6,6-difluoro bicyclic himbacine derivatives as par-1 receptor antagonistsYANG ZHIQIANG·Filed 2014·Application pending·0 cites
- 0952US2022089612A1Heterocyclic compounds as prmt5 inhibitorsANGEX PHARMACEUTICAL INC·Filed 2021·Application pending·0 cites
- 1047US11180497B2Cyclic compounds as immunomodulating agentsANGEX PHARMACEUTICAL INC·Filed 2018·Granted Nov 23, 2021·0 cites·25 claims
- 1146US11058775B2Insulin dimer-incretin conjugatesMERCK SHARP & DOHME·Filed 2017·Granted Jul 13, 2021·0 cites·22 claims
- 1243US11098046B2Macrocyclic compounds as TRK kinase inhibitors and uses thereofANGEX PHARMACEUTICAL INC·Filed 2018·Granted Aug 24, 2021·0 cites·21 claims
- 1341US10925876B2Methods for using triazolo-pyrazinyl soluble guanylate cyclase activators in fibrotic disordersMERCK SHARP & DOHME·Filed 2017·Granted Feb 23, 2021·0 cites·9 claims
- 1441US10780092B2Fused pyrazine derivatives useful as soluble guanylate cyclase stimulatorsMERCK SHARP & DOHME·Filed 2017·Granted Sep 22, 2020·0 cites·19 claims
- 1540US11358949B2Carbamate and urea compounds as multikinase inhibitorsANGEX PHARMACEUTICAL INC·Filed 2018·Granted Jun 14, 2022·0 cites·20 claims
- 1640US2010261741A1Quinazolinone T-Type Calcium Channel AntagonistsMERCK·Filed 2010·Application pending·0 cites
- 1738US2020369667A1Heterocyclic compounds as prmt5 inhibitorsANGEX PHARMACEUTICAL INC·Filed 2018·Application pending·0 cites
- 1838US2019175744A1Insulin-incretin conjugatesPALANI ANANDAN·Filed 2017·Application pending·0 cites
- 1924US9193697B2Oxazole derivatives useful as modulators of FAAHYANG ZHIQIANG·Filed 2011·Granted Nov 24, 2015·0 cites·4 claims
Join the waitlist — get patent alerts
Get an alert when Zhiqiang Yang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →